top of page
Image by National Cancer Institute

Specialized Tests

Tenpenny Integrative Medical Center offers a wide variety of integrative medicine tests that are generally not available through conventional medical practices. Your insurance may or may not pay some or all of the fees associated with these tests.

Click on the hyperlinks to learn specifics about the testing. Call 440-239-3438 for more information and pricing.

  • Adrenal Saliva Test

  • Breast Health Risk Assessment – Breast Thermography   learn more

  • Cardiovascular Risk Assessment  learn more

  • DirectLabs – order your test directly  learn more

  • Estrogen Ratio Testing  learn more

  • Functional Micronutrient Analysis  learn more

  • Hormone Testing and Balancing  learn more

  • Iodine testing: For thyroid imbalances and breast health  learn more

  • Thyroflex (non-invasive thyroid testing)   learn more

Advanced Testing for Cardiovascular Risk

LPP and LPP Plus™

Spectracell’s LPP™ test is the most advanced lipoprotein test currently available. Unlike traditional cholesterol tests, Spectracell’s LPP™ directly measures both the size and number of several classes of lipoprotein particles, including critical risk factors as cited by the National Cholesterol Education Program, giving an accurate assessment of cardiovascular risk.

Many patients understand that not all cholesterol is the same. There is the “good” HDL (High Density Lipoprotein) cholesterol and the “bad” LDL (Low Density Lipoprotein) cholesterol. However, different types of HDL and LDL exist and some are much more dangerous than others. The LPP™ test determines the specific number of particles in each lipoprotein subclass (HDL and LDL) for a much more accurate assessment of risk. For example, the LPP™ test measures RLP (remnant lipoprotein) and Lp(a), both very atherogenic, but with very different effective treatment options. A standard cholesterol test does not give this information, putting the clinician at a disadvantage when deciding the most effective clinical treatment for their patient.

advanced testin cardiovascula risk

Estrogen Ratio Testing

Hormones are one of the many ways our body`s cells communicate with each other. There are hundreds of different hormones in the body. The female hormones most commonly known are estrogen, progesterone and testosterone.

Estrogen is a term used to describe three different hormones manufactured by the ovaries. Estradiol, also known as “E2” is the most dominant hormone and the hormone generally in the highest concentrations, even after menopause. The other two hormones, Estriol (E3) and Estrone (E1), are in various concentrations. Estriol is important for vaginal secretions and estrone is important for bone health.

Testosterone is a member of the androgen family, which also includes DHEA and DHT. These hormones help with the regeneration of skin, bones muscles and other tissues. Low testosterone levels can lead to poor muscle tone, decreased sex drive and cardiovascular help. Adequate DHEA levels are important for energy and clear mental function. Progesterone is important for nervous system and thyroid health. Low progesterone has been linked to hot flashes, sleep disturbances, hair loss and irritability.

In addition to assessing hormone levels, every woman needs to assess her risk for breast cancer. There are many unknowns when it comes to hormone replacement and breast cancer risks. Why are certain tissues, such as the breast, susceptible to estrogen-induced cancer? Why are some women susceptible, but not others? Researchers at Rockefeller University have found that the body metabolizes estrogens into several different metabolites that can impact cancer development.

One metabolite, 2-hydroxy-estrone (2-OH), tends to inhibit cancer growth. Another, 16-a-hydroxy-estrone (16-OH), actually can stimulate tumor development. A woman’s “biochemical individuality” and liver metabolism determines which of these metabolites predominates. Studies have shown that measuring the ratio of these two metabolites provides an important indication of risk for future development of estrogen-sensitive cancers.

The Estronex™ 2/16 Test is a first morning urine test that measures the ratio of these two critical estrogen metabolites. A ratio of less than 2.0 indicates an increased long-term risk for breast, cervical, and other estrogen-sensitive cancers.

Importantly, nutritional interventions can help raise Estronex 2/16 ratios and decrease long-term risk.

estrogen ratio testing
bottom of page